Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.

Wiklund ED, Gao S, Hulf T, Sibbritt T, Nair S, Costea DE, Villadsen SB, Bakholdt V, Bramsen JB, Sørensen JA, Krogdahl A, Clark SJ, Kjems J.

PLoS One. 2011;6(11):e27840. doi: 10.1371/journal.pone.0027840. Epub 2011 Nov 22.

2.

Genome-wide DNA methylation profiling using Infinium® assay.

Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, Gunderson KL.

Epigenomics. 2009 Oct;1(1):177-200. doi: 10.2217/epi.09.14.

3.

Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults.

Kies MS, Boatright DH, Li G, Blumenschein G, El-Naggar AK, Brandon Gunn G, Lewin JS, Steinhaus GD, Sturgis EM.

Head Neck. 2012 Sep;34(9):1255-62. doi: 10.1002/hed.21906. Epub 2011 Oct 19.

4.

The role of the adenomatous polyposis coli (APC) in oral squamous cell carcinoma.

Pérez-Sayáns M, Suárez-Peñaranda JM, Herranz-Carnero M, Gayoso-Diz P, Barros-Angueira F, Gándara-Rey JM, García-García A.

Oral Oncol. 2012 Jan;48(1):56-60. doi: 10.1016/j.oraloncology.2011.09.001. Epub 2011 Sep 19. Review.

PMID:
21937258
5.

Dickkopf (Dkk)-3 and β-catenin expressions increased in the transition from normal oral mucosal to oral squamous cell carcinoma.

Fujii M, Katase N, Lefeuvre M, Gunduz M, Buery RR, Tamamura R, Tsujigiwa H, Nagatsuka H.

J Mol Histol. 2011 Dec;42(6):499-504. doi: 10.1007/s10735-011-9357-z. Epub 2011 Sep 20.

PMID:
21932035
6.

Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma.

Ravindran G, Devaraj H.

Clin Oral Investig. 2012 Aug;16(4):1275-88. doi: 10.1007/s00784-011-0605-0. Epub 2011 Sep 1.

PMID:
21881870
7.

DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer.

Lopez-Serra P, Esteller M.

Oncogene. 2012 Mar 29;31(13):1609-22. doi: 10.1038/onc.2011.354. Epub 2011 Aug 22. Review.

8.

Advances and applications of oral cancer basic research.

da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Woolgar JA, Bradford CR, Rodrigo JP, Rinaldo A, Hier MP, Kowalski LP.

Oral Oncol. 2011 Sep;47(9):783-91. doi: 10.1016/j.oraloncology.2011.07.004. Epub 2011 Jul 29. Review.

PMID:
21802978
9.

The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.

Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J.

Cancer Res. 2011 Sep 1;71(17):5765-78. doi: 10.1158/0008-5472.CAN-11-0368. Epub 2011 Jul 27.

10.

Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.

Gasche JA, Hoffmann J, Boland CR, Goel A.

Int J Cancer. 2011 Sep 1;129(5):1053-63. doi: 10.1002/ijc.25764. Epub 2011 Jan 7.

11.

Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.

Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z.

Oral Oncol. 2011 Aug;47(8):702-8. doi: 10.1016/j.oraloncology.2011.05.014. Epub 2011 Jun 22.

PMID:
21697000
12.

MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.

Langevin SM, Stone RA, Bunker CH, Lyons-Weiler MA, LaFramboise WA, Kelly L, Seethala RR, Grandis JR, Sobol RW, Taioli E.

Cancer. 2011 Apr 1;117(7):1454-62. doi: 10.1002/cncr.25689. Epub 2010 Nov 8.

13.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.

Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.

14.

A novel approach to overcome temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy.

Jiang G, Wei ZP, Pei DS, Xin Y, Liu YQ, Zheng JN.

Biochem Biophys Res Commun. 2011 Mar 18;406(3):311-4. doi: 10.1016/j.bbrc.2011.02.042. Epub 2011 Feb 15. Review.

PMID:
21329652
15.

miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion.

Zheng J, Xue H, Wang T, Jiang Y, Liu B, Li J, Liu Y, Wang W, Zhang B, Sun M.

J Cell Biochem. 2011 Mar;112(3):872-80. doi: 10.1002/jcb.22995.

PMID:
21328460
16.

Oncogenic role of RUNX3 in head and neck cancer.

Kudo Y, Tsunematsu T, Takata T.

J Cell Biochem. 2011 Feb;112(2):387-93. doi: 10.1002/jcb.22967. Review.

PMID:
21268058
17.

Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa.

Paluszczak J, Misiak P, Wierzbicka M, Woźniak A, Baer-Dubowska W.

Oral Oncol. 2011 Feb;47(2):104-7. doi: 10.1016/j.oraloncology.2010.11.006. Epub 2010 Dec 13.

PMID:
21147548
18.

Genome-wide DNA methylation profiling.

Bibikova M, Fan JB.

Wiley Interdiscip Rev Syst Biol Med. 2010 Mar-Apr;2(2):210-23. doi: 10.1002/wsbm.35. Review.

PMID:
20836023
19.

WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.

Pannone G, Bufo P, Santoro A, Franco R, Aquino G, Longo F, Botti G, Serpico R, Cafarelli B, Abbruzzese A, Caraglia M, Papagerakis S, Lo Muzio L.

Oncol Rep. 2010 Oct;24(4):1035-41.

PMID:
20811686
20.

CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.

Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M.

Oncogene. 2010 Dec 2;29(48):6390-401. doi: 10.1038/onc.2010.361. Epub 2010 Aug 30.

Supplemental Content

Support Center